Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $863M (100.0% shares, 0.0% debt)

Holdings (39)

INSM INSMED INC 16.6%
Value $143M Shares 2,138,963 Share Price $67.00 * Est. Cost/Share $17.79 Unrealized @ Report Date +118.0%
BMRN BIOMARIN PHARMACEUTICAL INC 10.8%
Value $93.05M Shares 1,130,167 Share Price $82.33 Est. Cost/Share $83.16 Unrealized @ Report Date +0.1%
FOLD AMICUS THERAPEUTICS INC 10.4%
Value $89.58M Shares 9,029,843 Share Price $9.92 * Est. Cost/Share $9.63 Unrealized @ Report Date +6.6%
UTHR UNITED THERAPEUTICS CORP 9.9%
Value $85.03M Shares 266,914 Share Price $318.55 * Est. Cost/Share $89.23 Unrealized @ Report Date +196.6%
BIIB BIOGEN INC 7.8%
Value $67.01M Shares 289,050 Share Price $231.82 * Est. Cost/Share $264.98 Unrealized @ Report Date -18.0%
STAA STAAR SURGICAL CO 7.6%
Value $65.78M Shares 1,381,619 Share Price $47.61 * Est. Cost/Share $24.23 Unrealized @ Report Date +80.8%
— ALNYLAM PHARMACEUTICALS INC 5.2%
Value $44.5M Shares 183,123 Share Price $243.00 Est. Cost/Share $243.00 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 4.6%
Value $39.31M Shares 2,418,841 Share Price $16.25 Est. Cost/Share $28.41 Unrealized @ Report Date -43.2%
PRTA PROTHENA CORP PLC 4.0%
Value $34.39M Shares 1,666,378 Share Price $20.64 * Est. Cost/Share $21.46 Unrealized @ Report Date +0.9%
SRPT SAREPTA THERAPEUTICS INC 3.7%
Value $31.87M Shares 201,683 Share Price $158.00 * Est. Cost/Share $111.32 Unrealized @ Report Date +15.4%
ANAB ANAPTYSBIO INC 2.3%
Value $20.14M Shares 803,641 Share Price $25.06 * Est. Cost/Share $19.13 Unrealized @ Report Date +21.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.0%
Value $16.97M Shares 2,116,403 Share Price $8.02 * Est. Cost/Share $5.23 Unrealized @ Report Date +104.8%
— REVANCE THERAPEUTICS INC 1.6%
Value $13.51M Shares 5,257,086 Share Price $2.57 Est. Cost/Share $21.40 Unrealized @ Report Date —
ALKS ALKERMES PLC 1.4%
Value $11.94M Shares 495,592 Share Price $24.10 Est. Cost/Share $22.36 Unrealized @ Report Date +9.7%
— SAGE THERAPEUTICS INC 1.3%
Value $10.98M Shares 1,010,833 Share Price $10.86 Est. Cost/Share $42.50 Unrealized @ Report Date —
EHTH EHEALTH INC 1.2%
Value $10.65M Shares 2,350,190 Share Price $4.53 * Est. Cost/Share $38.13 Unrealized @ Report Date -86.8%
NVCR NOVOCURE LTD 1.1%
Value $9.625M Shares 561,908 Share Price $17.13 * Est. Cost/Share $58.84 Unrealized @ Report Date -70.1%
ALGN ALIGN TECHNOLOGY INC 1.1%
Value $9.119M Shares 37,772 Share Price $241.43 * Est. Cost/Share $149.18 Unrealized @ Report Date +86.6%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $8.319M Shares 405,193 Share Price $20.53 Est. Cost/Share $16.84 Unrealized @ Report Date +24.3%
— ACELYRIN INC 0.9%
Value $7.564M Shares 1,715,180 Share Price $4.41 Est. Cost/Share $6.75 Unrealized @ Report Date —
— NEVRO CORP 0.7%
Value $6.318M Shares 750,371 Share Price $8.42 Est. Cost/Share $21.87 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.7%
Value $6.053M Shares 111,717 Share Price $54.18 * Est. Cost/Share $6.71 Unrealized @ Report Date +799.1%
GOSS GOSSAMER BIO INC 0.7%
Value $5.655M Shares 6,277,093 Share Price $0.90 * Est. Cost/Share $1.58 Unrealized @ Report Date -52.6%
— ELEVATION ONCOLOGY INC 0.6%
Value $4.86M Shares 1,800,106 Share Price $2.70 Est. Cost/Share $4.52 Unrealized @ Report Date —
— BLUEBIRD BIO INC 0.5%
Value $4.56M Shares 4,633,351 Share Price $0.98 Est. Cost/Share $1.35 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.5%
Value $4.427M Shares 5,102,193 Share Price $0.87 Est. Cost/Share $16.36 Unrealized @ Report Date —
— VERVE THERAPEUTICS INC 0.3%
Value $2.81M Shares 575,817 Share Price $4.88 Est. Cost/Share $13.94 Unrealized @ Report Date —
NUVB NUVATION BIO INC 0.3%
Value $2.256M Shares 772,652 Share Price $2.92 * Est. Cost/Share $1.92 Unrealized @ Report Date +58.9%
MIRM MIRUM PHARMACEUTICALS INC 0.3%
Value $2.212M Shares 64,700 Share Price $34.19 * Est. Cost/Share $15.56 Unrealized @ Report Date +68.5%
RLMD RELMADA THERAPEUTICS INC 0.3%
Value $2.197M Shares 732,400 Share Price $3.00 * Est. Cost/Share $3.27 Unrealized @ Report Date +10.6%
TSHA TAYSHA GENE THERAPIES INC 0.2%
Value $1.817M Shares 811,268 Share Price $2.24 * Est. Cost/Share $2.02 Unrealized @ Report Date +43.7%
STOK STOKE THERAPEUTICS INC 0.2%
Value $1.7M Shares 125,861 Share Price $13.51 Est. Cost/Share $6.06 Unrealized @ Report Date +122.9%
HUM HUMANA INC 0.2%
Value $1.489M Shares 3,985 Share Price $373.65 * Est. Cost/Share $369.63 Unrealized @ Report Date -10.7%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $910K Shares 110,719 Share Price $8.22 * Est. Cost/Share $23.56 Unrealized @ Report Date -71.4%
VYNE VYNE THERAPEUTICS INC PIPE 0.1%
Value $878K Shares 445,434 Share Price $1.97 * Est. Cost/Share $3.12 Unrealized @ Report Date -20.0%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $746K Shares 225,465 Share Price $3.31 * Est. Cost/Share $5.95 Unrealized @ Report Date -34.1%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value $627K Shares 569,832 Share Price $1.10 * Est. Cost/Share $1.19 Unrealized @ Report Date -1.5%
— GENERATION BIO CO 0.0%
Value $424K Shares 150,475 Share Price $2.82 Est. Cost/Share $2.82 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $411K Shares 24,500 Share Price $16.78 * Est. Cost/Share $27.01 Unrealized @ Report Date -47.3%